239 related articles for article (PubMed ID: 38602143)
1. A molecular journey on the pathogenesis of primary hyperoxaluria.
Cellini B
Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):398-404. PubMed ID: 38602143
[TBL] [Abstract][Full Text] [Related]
2. Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.
Lai C; Pursell N; Gierut J; Saxena U; Zhou W; Dills M; Diwanji R; Dutta C; Koser M; Nazef N; Storr R; Kim B; Martin-Higueras C; Salido E; Wang W; Abrams M; Dudek H; Brown BD
Mol Ther; 2018 Aug; 26(8):1983-1995. PubMed ID: 29914758
[TBL] [Abstract][Full Text] [Related]
3. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
Kukreja A; Lasaro M; Cobaugh C; Forbes C; Tang JP; Gao X; Martin-Higueras C; Pey AL; Salido E; Sobolov S; Subramanian RR
Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
[TBL] [Abstract][Full Text] [Related]
4. 4-Hydroxyproline metabolism and glyoxylate production: A target for substrate depletion in primary hyperoxaluria?
Coulter-Mackie MB
Kidney Int; 2006 Dec; 70(11):1891-3. PubMed ID: 17130820
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of primary hyperoxaluria: clues to innovative treatments.
Dindo M; Conter C; Oppici E; Ceccarelli V; Marinucci L; Cellini B
Urolithiasis; 2019 Feb; 47(1):67-78. PubMed ID: 30430197
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperoxalurias: disorders of glyoxylate detoxification.
Salido E; Pey AL; Rodriguez R; Lorenzo V
Biochim Biophys Acta; 2012 Sep; 1822(9):1453-64. PubMed ID: 22446032
[TBL] [Abstract][Full Text] [Related]
7. Primary hyperoxaluria.
Watts RW
Contrib Nephrol; 1997; 122():143-59. PubMed ID: 9399058
[No Abstract] [Full Text] [Related]
8. Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure.
van Harskamp D; Garrelfs SF; Oosterveld MJS; Groothoff JW; van Goudoever JB; Schierbeek H
Anal Chem; 2020 Jan; 92(2):1826-1832. PubMed ID: 31867958
[TBL] [Abstract][Full Text] [Related]
9. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
[TBL] [Abstract][Full Text] [Related]
10. Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
Belostotsky R; Pitt JJ; Frishberg Y
J Mol Med (Berl); 2012 Dec; 90(12):1497-504. PubMed ID: 22729392
[TBL] [Abstract][Full Text] [Related]
11. [Primary hyperoxaluria].
De Pauw L; Toussaint C
Rev Med Brux; 1996 Apr; 17(2):67-74. PubMed ID: 8685551
[TBL] [Abstract][Full Text] [Related]
12. Effect of alanine supplementation on oxalate synthesis.
Wood KD; Freeman BL; Killian ME; Lai WS; Assimos D; Knight J; Fargue S
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165981. PubMed ID: 33002578
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the identification and management of inherited hyperoxalurias.
Sas DJ; Harris PC; Milliner DS
Urolithiasis; 2019 Feb; 47(1):79-89. PubMed ID: 30535828
[TBL] [Abstract][Full Text] [Related]
14. Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs.
Huang Y; Zhu W; Zhou J; Huang Q; Zeng G
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785918
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.
Li X; Knight J; Fargue S; Buchalski B; Guan Z; Inscho EW; Liebow A; Fitzgerald K; Querbes W; Todd Lowther W; Holmes RP
Biochim Biophys Acta; 2016 Feb; 1862(2):233-9. PubMed ID: 26655602
[TBL] [Abstract][Full Text] [Related]
16. The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization.
Dindo M; Mandrile G; Conter C; Montone R; Giachino D; Pelle A; Costantini C; Cellini B
Mol Genet Metab; 2020; 131(1-2):171-180. PubMed ID: 32792227
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperoxalurias: diagnosis and treatment.
Ben-Shalom E; Frishberg Y
Pediatr Nephrol; 2015 Oct; 30(10):1781-91. PubMed ID: 25519509
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.
Cochat P; Hulton SA; Acquaviva C; Danpure CJ; Daudon M; De Marchi M; Fargue S; Groothoff J; Harambat J; Hoppe B; Jamieson NV; Kemper MJ; Mandrile G; Marangella M; Picca S; Rumsby G; Salido E; Straub M; van Woerden CS;
Nephrol Dial Transplant; 2012 May; 27(5):1729-36. PubMed ID: 22547750
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria.
Knight J; Holmes RP
Am J Nephrol; 2005; 25(2):171-5. PubMed ID: 15849464
[TBL] [Abstract][Full Text] [Related]
20. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
